By credit to Ibe
Parties concerned lamented that the $100 billion COVID-19 intervention fund for the country’s health sector has failed to achieve its goal of reducing medical tourism from Nigerians.
In response to the pandemic, the Central Bank of Nigeria (CBN) provided a NZ$100 billion credit line in 2020 to support healthcare and drug manufacturers to upgrade their equipment and on-site manufacturing facilities to stop medical tourism outside the country.
The intervention aimed to stimulate economic activity in the sector locally so that pharmaceutical products and services are readily available to serve Nigerians, thereby diversifying and expanding the sector’s local capacity.
This scheme is expected to increase private and public investment in the health sector, improve medical care and reduce medical tourism to improve foreign exchange savings.
Unfortunately, despite this huge intervention, the available records show that Nigerians are still traveling in droves to other countries to take care of their health. Problems.
In response, the chairman of the Apapa branch of the Association of Manufacturers from Nigeria (MAN), Mr. Frank Onyebu opined that $100 billion will not really solve Nigeria’s health problems as people who still go on medical tourism are eligible as only the local pharmaceutical industry can’t solve this problem.
He lamented that Nigerian medical personnel are still leaving the country due to poor working conditions, and some obsolete facilities in most of the country’s hospitals have not yet been replaced government. “Therefore, due to the lack of opportunities and facilities or infrastructure, those with the resources to improve treatment abroad still travel as part of medical tourism.” He said.
Assigning studies as part of the decisions to produce their own raw materials, he noted that $ 100 billion was mainly intended for pharmaceutical companies to improve their production capacities, because during the period when the pandemic raged, the supply chain was interrupted.
“We need to start now, when there is no COVID-19, to abandon our fire-fighting approach to problems and create working institutions in different sectors.
We must begin with the principles of inquiry. Find out how we can produce key raw materials here,” adding that most pharmaceutical companies source raw materials from outside the country.
“We need to produce these basic resources, if we don’t, when problems like this come up again, we’ll be in big trouble.” He advised
He noted that the money raised by some companies was more focused on improving what they already had because there wasn’t enough to install the machines.
Onyebu went on to say, “There are people who go abroad for any reason, especially people who are in…